← Open Payments lookup

JEFFREY HANSEN: Open Payments

NPI 1356410419 · VANCOUVER, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$491,853 in 590 payments from 13 companies in 2025. Trend: 2023 $433,120 · 2024 $462,937 · 2025 $491,853

Speaker / faculty: $335,993Travel & lodging: $65,386Consulting: $52,868Honoraria: $25,025Food & beverage: $12,569Education: $12
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.115$112,281
ABBVIE INC.96$91,132
Janssen Pharmaceuticals, Inc56$62,513
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)65$52,373
Teva Pharmaceuticals USA, Inc.54$49,715
Axsome Therapeutics, Inc.47$28,903
Otsuka America Pharmaceutical, Inc.52$28,764
E.R. Squibb & Sons, L.L.C.38$26,654
Alkermes, Inc.26$20,361
Vanda Pharmaceuticals Inc.29$18,975

Products named: INGREZZA, VRAYLAR, SPRAVATO, CAPLYTA, AUSTEDO XR, Auvelity, REXULTI, COBENFY.

Industry payments across WA — which companies pay providers there.